Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

RDM is delighted to announce the conferment of three new Associate Professors. Each of our new Associate Professors has been awarded the title in recognition of their contributions to research, teaching and citizenship at the University and beyond.

Profile pictures of the new RDM Associate Professors 2024

Congratulations to:

Dr Elizabeth Ormondroyd, Associate Professor of Social and Ethical aspects of Genomic Medicine

Dr Ormondroyd obtained a PhD from King’s College London / Imperial Cancer Research Fund. After a postdoctoral position at the National Institute for Medical Research, she studied for an MSc in Genetic Counselling at the University of Manchester. She was Senior Research Fellow at the Institute of Cancer Research at the Royal Marsden Hospital, before moving to Oxford in 2008 to join the Division of Cardiovascular Medicine.

Dr Ormonroyd’s research focuses on the social and ethical implications of genomic technology in healthcare. Her work involves qualitative and quantitative research with patients, healthcare and other professionals, to generate evidence to inform clinical use of genomic technology. A recent focus has been understanding the implications of unexpected genomic risk information, for example as ‘secondary findings’, for patients and healthcare services. Dr Ormondroyd also works closely with the inherited cardiac conditions service in Oxford University Hospitals NHS Foundation Trust. As genetic therapies for cardiomyopathy begin to be developed in the CureHeart programme, she is researching the acceptability, perceived value, and ethical implications of genetic therapies for this group of disorders.

Dr Michael Desborough, Associate Professor of Haematology

Dr Desborough has a long association with RDM and was a National Institute of Health Research (NIHR) academic clinical fellow, NHS Blood and Transplant clinical research fellow, NIHR clinical lecturer and honorary senior clinical lecturer. He is a consultant haematologist at Oxford University Hospitals NHS Foundation Trust where he leads the immunohaematology service and is the lead for the immune thrombocytopenia and thrombotic thrombocytopenic purpura specialised centres. He completed his DPhil on desmopressin for treatment of thrombocytopenia or platelet dysfunction at RDM in 2017. He was awarded the British Society for Haematology NIHR Researcher of the Year in April.

His research is focused on clinical trials of medications to reduce bleeding for adults with intracerebral haemorrhage; and treatment and prevention of intracerebral bleeding for babies with fetal and neonatal alloimmune thrombocytopenia.

Dr Michael Pavlides, Associate Professor of Hepatology

Dr Pavlides studied medicine at University College London Medical School. After junior placements in London and Cornwall he moved to Oxford in 2007 for Core Medical Training and then specialist training in Gastroenterology, Hepatology and General Internal Medicine. During his specialist training he undertook a period of research and was awarded a DPhil from the University of Oxford in 2017. Since then, he has been Head of Liver Imaging Research at the Oxford Centre for Clinical Magnetic Resonance Research (OCMR) and led a global multi-centre study evaluating imaging biomarkers in liver disease. Dr Pavlides took up a position as consultant hepatologist at the Oxford University Hospitals NHS Foundation Trust in December 2023.

Dr Pavlides’ continues in his role as Head of Liver Imaging Research in OCMR where he maintains an active portfolio of research studies. The Pavlides group investigates how MR techniques can be used to improve the care of patients with liver disease.

Applying for Associate Professor status

The nominations for Associate Professor status are made by the Head of Department Professor Keith Channon, and a body of evidence is assessed by the Medical Sciences Divisional Committee.
The stated eligibility criteria for the title of Associate Professor is:

  • Research as a key focus of their role;
  • Teaching role is comparable with that of a substantive associate professor, to include supervision;
  • Teaching and administrative duties are carried out at no less a level of excellence than is expected of a substantive associate professor;
  • Contribute to other departmental duties, academic and otherwise, demonstrating the level of citizenship expected of a substantive associate professor, and personal contribution to Equality, Diversity and Inclusion actions in their group.

More information about the conferment of the title of Associate Professor can be found on the Medical Science Division webpages. The Researcher's Trailmap has been created to help you plan your research journey and can used to find personal, research and career development opportunities.

We want to hear about your news!

Publishing a paper? Just won an award? Get in touch with